[Enhancement of resistance to microbial infection].
D000119:Acetylmuramyl-Alanyl-Isoglutamine / Q000031:analogs & derivatives / Q000627:therapeutic use; D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D001424:Bacterial Infections / Q000276:immunology*; D001426:Bacterial Proteins; D002634:Chemotaxis, Leukocyte / Q000187:drug effects; D006023:Glycoproteins / Q000627:therapeutic use; D008297:Male; D051379:Mice; D009504:Neutrophils / Q000276:immunology
D000276:Adjuvants, Immunologic; D000900:Anti-Bacterial Agents; D001426:Bacterial Proteins; D006023:Glycoproteins; D000119:Acetylmuramyl-Alanyl-Isoglutamine; C037567:glycoprotein, Klebsiella pneumoniae; C036866:romurtide